HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Speck, U. Articles by Hamm, B. Search for Related Content PubMed PubMed Citation Articles by Speck, U. Articles by Hamm, B.

Neointima Inhibition: Comparison of Effectiveness of Non–Stent-based Local Drug Delivery and a Drug-eluting Stent in Porcine Coronary Arteries¹

¹ From the Department of Radiology, Charité Humboldt-University Berlin, Schumannstr 20-21, D 10117 Berlin, Germany (U.S., C.A., C.B., B.H.); Department of Internal Medicine III, University Hospital, Homburg/Saar, Germany (B.S., M.B.); and Biometry and Applied Statistics, Berlin, Germany (J.D.). From the 2004 RSNA Annual Meeting. Received July 26, 2005; revision requested September 30; revision received October 13; final version accepted November 14. Supported by a grant from the Ministry of Economics and Technology. Address correspondence to U.S. (e-mail: ulrich.speck{at}charite.de).

Purpose: To compare the inhibition of neointimal proliferation by using non–stent-based local drug delivery and a drug-eluting stent in porcine coronary arteries.

Materials and Methods: Experiments were conducted with permission of the animal protection committee of the local government. Paclitaxel was either dissolved in a nonionic contrast medium or coated on balloons. Stents were crimped on the coated balloons. Effectiveness was tested in 22 pigs. Two coronary stents were placed in each pig, and slight overstretch was applied. The animals were treated as follows: group A (control group), uncoated balloons, bare stents, and "plain" contrast medium; group B, same treatment as group A, but with paclitaxel in the contrast medium; group C, paclitaxel-coated balloons, with premounted bare stents and plain contrast medium; and group D, sirolimus-eluting stents, noncoated balloons, and plain contrast medium. Stenosis was assessed 4 weeks later at angiography and histomorphometry. For exploratory purposes, continuous variables of quantitative coronary angiography and histomorphometry were compared by using analysis of variance.

Results: Results at follow-up angiography indicated a mean of 1.00 mm ± 0.18 (standard deviation) lumen diameter loss in the control group and 0.14 mm ± 0.18 loss in the group treated with the paclitaxel-coated balloon (group C; P < .001). Findings at histomorphometry confirmed the effectiveness of drug delivery, with the most impressive inhibition of neointimal proliferation from coated balloons—the neointimal area was 2.4 mm² ± 0.3 (P < .01 vs all other groups), compared with 5.2 mm² ± 0.3 in group A (control group), 4.3 mm² ± 0.3 in group B, and 3.8 mm² ± 0.3 in group D.

Conclusion: In spite of the short intima contact time, paclitaxel coated on the balloon inhibits neointimal formation in the porcine model of coronary stent placement.

© RSNA, 2006

This article has been cited by other articles:

				M. Werk, S. Langner, B. Reinkensmeier, H.-F. Boettcher, G. Tepe, U. Dietz, N. Hosten, B. Hamm, U. Speck, and J. Ricke Inhibition of Restenosis in Femoropopliteal Arteries: Paclitaxel-Coated Versus Uncoated Balloon: Femoral Paclitaxel Randomized Pilot Trial Circulation, September 23, 2008; 118(13): 1358 - 1365. [Abstract] [Full Text] [PDF]

				G. Tepe, T. Zeller, T. Albrecht, S. Heller, U. Schwarzwalder, J.-P. Beregi, M.D. C. D. Claussen, A. Oldenburg, B. Scheller, and U. Speck Local Delivery of Paclitaxel to Inhibit Restenosis during Angioplasty of the Leg N. Engl. J. Med., February 14, 2008; 358(7): 689 - 699. [Abstract] [Full Text] [PDF]

				B. Scheller, U. Speck, and M. Bohm Prevention of restenosis: is angioplasty the answer? Heart, May 1, 2007; 93(5): 539 - 541. [Abstract] [Full Text] [PDF]

				Y. Lim, T.-J. Kim, Y.-R. Jin, D.-W. Kim, J.-S. Kwon, J.-H. Son, J.-C. Jung, M. A. Avery, D. J. Son, J. T. Hong, et al. Epothilone B Inhibits Neointimal Formation after Rat Carotid Injury through the Regulation of Cell Cycle-Related Proteins J. Pharmacol. Exp. Ther., May 1, 2007; 321(2): 648 - 655. [Abstract] [Full Text] [PDF]

				B. Scheller, C. Hehrlein, W. Bocksch, W. Rutsch, D. Haghi, U. Dietz, M. Bohm, and U. Speck Treatment of Coronary In-Stent Restenosis with a Paclitaxel-Coated Balloon Catheter N. Engl. J. Med., November 16, 2006; 355(20): 2113 - 2124. [Abstract] [Full Text] [PDF]